Position in GH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,367,814
-$516,669 QoQ
Shares Held
14,808
-19.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $40,884,850 across 12 Diagnostics & Research names. GH ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TWST |
Twist Bioscience Corp
|
284,589 | $13,523,669 | |
| 2 | ILMN |
Illumina, Inc.
|
55,145 | $6,797,172 | |
| 3 | NTRA |
Natera, Inc.
|
25,498 | $5,099,345 | |
| 4 | VCYT |
Veracyte, Inc.
|
124,331 | $4,004,701 | |
| 5 | WGS |
GeneDx Holdings Corp.
|
57,759 | $3,709,282 | |
| 6 | PSNL |
Personalis, Inc.
|
323,374 | $2,059,892 | |
| 7 | CDNA |
CareDx, Inc.
|
101,747 | $1,766,327 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
14,808 | $1,367,814 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,367,814 | 14,808 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,884,483 | 18,450 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $941,573 | 15,070 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,358,660 | 45,324 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $383,570 | 9,004 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||